scholarly journals Implementing a non-steroidal anti-inflammatory drugs communication bundle in remote and rural pharmacies and dispensing practices

2018 ◽  
Vol 7 (3) ◽  
pp. e000303 ◽  
Author(s):  
Clare Morrison ◽  
Tracy Beauchamp ◽  
Helen MacDonald ◽  
Michelle Beattie
Keyword(s):  
Primary Care ◽  
Patient Safety ◽  
Hospital Admissions ◽  
Safety Information ◽  
Care Bundle ◽  
Community Pharmacies ◽  
Drug Reactions ◽  
Dispensing Practices ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with more emergency hospital admissions due to adverse drug reactions than any other class of medicine. One way to tackle this is to ensure that patients understand how to take their NSAIDs in the safest way possible. The aim of this project was to ensure that key safety information is given to every patient, every time an NSAID is sold or dispensed. The project started as part of the Scottish Patient Safety Programme’s Pharmacy in Primary Care Collaborative. An NSAIDs bundle was developed, tested and implemented using the Model for Improvement as a framework, including multiple Plan, Do, Study, Act cycles. The bundle, and associated improvement package, was developed during phase I of the project and tested by seven teams (five pharmacies and two dispensing practices). Phase II tested the spread of the defined improvement package across an additional five community pharmacies and eight dispensing general practitioner practices. The project has resulted in the development of a simple package to improve communication with patients about NSAIDs, which should enable patients to take NSAIDs safely. Three key safety messages were developed, typical for a care bundle approach, and simple tools were employed to ensure every patient received these three key messages every time. The project aim of 95% compliance with the NSAIDs bundle within the seven initial sites by December 2015 was achieved (when an exclusion was applied). The spread of the defined improvement package to a further 13 sites was achieved by December 2016. By December 2017, all 81 community pharmacies in National Health Service (NHS) Highland had agreed to implement the NSAIDs bundle. In June 2018, a national NSAIDs bundle, based on the NHS Highland work, was introduced in community pharmacies across Scotland. We also believe that the approach could be replicated for other high-risk medicines.

scholarly journals Adverse drug reactions in a primary care population prescribed non-steroidal anti-inflammatory drugs

2015 ◽  
Vol 33 (3) ◽  
pp. 163-169 ◽  
Author(s):  
Aafke R. Koffeman ◽  
Amanda R. Van Buul ◽  
Vera E. Valkhoff ◽  
Geert W. 'T Jong ◽  
Patrick J. E. Bindels ◽  
...  
Keyword(s):  
Primary Care ◽  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Primary Care Population ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

scholarly journals Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool

2005 ◽  
Vol 19 (5) ◽  
pp. 285-303 ◽  
Author(s):  
Sander JO Veldhuyzen van Zanten ◽  
Marc Bradette ◽  
Naoki Chiba ◽  
David Armstrong ◽  
Alan Barkun ◽  
...  
Keyword(s):  
Primary Care ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Clinical Management ◽  
Management Tool ◽  
Noninvasive Testing ◽  
Ulcer Bleeding ◽  
High Dose ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

The present paper is an update to and extension of the previous systematic review on the primary care management of patients with uninvestigated dyspepsia (UD). The original publication of the clinical management tool focused on the initial four- to eight-week assessment of UD. This update is based on new data from systematic reviews and clinical trials relevant to UD. There is now direct clinical evidence supporting a test-and-treat approach in patients with nondominant heartburn dyspepsia symptoms, and head-to-head comparisons show that use of a proton pump inhibitor is superior to the use of H2-receptor antagonists (H2RAs) in the initial treatment of Helicobacter pylori-negative dyspepsia patients. Cisapride is no longer available as a treatment option and evidence for other prokinetic agents is lacking. In patients with long-standing heartburn-dominant (ie, gastroesophageal reflux disease) and nonheartburn-dominant dyspepsia, a once-in-a-lifetime endoscopy is recommended. Endoscopy should also be considered in patients with new-onset dyspepsia that develops after the age of 50 years. Conventional nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and cyclooxygenase-2-selective inhibitors can all cause dyspepsia. If their use cannot be discontinued, cotherapy with either a proton pump inhibitor, misoprostol or high-dose H2RAs is recommended, although the evidence is based on ulcer data and not dyspepsia data. In patients with nonheartburn-dominant dyspepsia, noninvasive testing for H pylori should be performed and treatment given if positive. When starting nonsteroidal anti-inflammatory drugs for a prolonged course, testing and treatment with H2RAs are advised if patients have a history of previous ulcers or ulcer bleeding.

Barriers to the use of patient safety information sources by community pharmacies

2019 ◽  
Vol 15 (7) ◽  
pp. 895-901 ◽  
Author(s):  
James R. Barker ◽  
Todd C. Boyle ◽  
Lisa Tay ◽  
Andrea Bishop ◽  
Bobbi Morrison ◽  
...  
Keyword(s):  
Patient Safety ◽  
Information Sources ◽  
Safety Information ◽  
Community Pharmacies

Professional Advice and the Utilization of Non-Steroidal Anti-Inflammatory Drugs at Community Pharmacies in the United Arab Emirates

2003 ◽  
Vol 21 (4) ◽  
pp. 377-388
Author(s):  
M. Y. Hasan ◽  
M. Das ◽  
A. Bener
Keyword(s):  
Side Effects ◽  
United Arab Emirates ◽  
Disease Duration ◽  
Community Pharmacies ◽  
Self Medication ◽  
Professional Advice ◽  
Duration Of Disease ◽  
Inflammatory Drugs ◽  
The Common ◽  
Anti Inflammatory

The present study examined the pattern of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in relation to the source of advice. Ten community pharmacies in the United Arab Emirates were randomly selected and patients visiting these sites were interviewed using a standard questionnaire. The interview covered “source of advice,” “name of medicine,” “type of disease,” “duration of disease,” and “knowledge of adverse effects and drug interactions.” After a month the patients were contacted. On average 22.7% of prescriptions contained NSAIDs and 17.5% of visits were for these drugs. Advice from physicians was given to 33.3%, from pharmacists 32.5%, from friends 18.8%, and 15.4% depended on themselves. Other medicines were taken by 14.5% and 12% suffered from gastrointestinal upsets. Paracetamol followed by ibuprofen and diclofenac were the most frequently utilized agents. Headache, fever, and musculoskeletal pain were the common complaints. A month later, 50.7% of the patients continued taking their medications. This study revealed an association between the source of advice and knowledge of side effects. It is argued that, although self-care is important, professional advice in its support is essential since unsupervised self-medication exposes the patient to harmful consequences.

The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands

2010 ◽  
Vol 62 (3) ◽  
pp. 243-248 ◽  
Author(s):  
Antje Neubert ◽  
Katia Verhamme ◽  
Macey L. Murray ◽  
Gino Picelli ◽  
Yingfen Hsia ◽  
...  
Keyword(s):  
Primary Care ◽  
The Netherlands ◽  
Paediatric Primary Care ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
The Uk

Utilisation of Non-steroidal Anti-inflammatory Drugs (NSAIDs) through Community Pharmacies in Malaysia

2005 ◽  
Vol 17 (2) ◽  
pp. 117-123 ◽  
Author(s):  
S.S. Chua ◽  
T. Paraidathathu
Keyword(s):  
Public Health ◽  
Shoulder Pain ◽  
Community Pharmacists ◽  
Health Problems ◽  
Community Pharmacies ◽  
Inflammatory Drugs ◽  
Cox 2 ◽  
Anti Inflammatory

This study was conducted to evaluate the use of non-steroidal anti-inflammatory drugs (NSAIDs) by consumers who obtained these drugs from community pharmacies. Factors that influenced community pharmacists in their choice of NSAIDs were also determined. Personal interviews were conducted on consumers who visited the 25 participating community pharmacies throughout Malaysia. Of the 389 respondents, 49% requested for an NSAID by name, 42% asked the pharmacist to recommend a medication and 9% had a doctor's prescription. NSAIDs were mainly purchased for joint/shoulder pain and the most commonly dispensed was diclofenac. Elderly respondents were more likely to be dispensed a selective COX-2 inhibitor than those below 60. NSAIDs were recommended based mainly on the pharmacist's perception of their efficacy, cost and safety. Community pharmacists play an important role in assisting patients in choosing the most appropriate NSAID for their health problems. Asia Pac J Public Health 2005; 17(2): 117-123.

Sign in / Sign up

Export Citation Format

Share Document